Due to CKD, which contraindicates several antidiabetic agents, and also due to the advanced stage of diabetes of most patients, a low number of diabetic patients were only treated with oral antidiabetic agents, not enabling proper statistical comparison of sTfR levels between these patients and those under insulin therapy. This evidence concerns the gene TFRC and chronic kidney disease.